SCHEMBL25974136

SCHEMBL25974136

Oc1ccc(-c2cccnc2Nc2ccc(C(F)(F)F)cc2)cc1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 6/20 0.48
▸ GRM4 Q14833 1/20 0.45
▸ TRPV1 Q8NER1 7/20 0.44
▸ RIPK1 Q13546 1/20 0.43
▸ BRD4 O60885 1/20 0.41
▸ TUBB4A P04350 1/20 0.41
▸ TUBB P07437 1/20 0.41
▸ TUBA3C P0DPH7 1/20 0.41
▸ TUBA1B P68363 1/20 0.41
▸ TUBA4A P68366 1/20 0.41
▸ TUBB4B P68371 1/20 0.41
▸ TUBB3 Q13509 1/20 0.41
▸ TUBB2A Q13885 1/20 0.41
▸ TUBB8 Q3ZCM7 1/20 0.41
▸ TUBA3E Q6PEY2 1/20 0.41
▸ TUBA1A Q71U36 1/20 0.41
▸ TUBA1C Q9BQE3 1/20 0.41
▸ TUBB6 Q9BUF5 1/20 0.41
▸ TUBB2B Q9BVA1 1/20 0.41
▸ TUBB1 Q9H4B7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25974137 0.88 TRPV1 (0.49) EPHX2TRPV1
SCHEMBL25974055 0.88 EPHX2 (0.46) EPHX2TRPV1TUBB4ATUBBTUBA3C
SCHEMBL25974054 0.84 TRPV1 (0.44) EPHX2TRPV1
SCHEMBL25974317 0.83 PIP4K2A (0.47) GRM4RIPK1
SCHEMBL25974206 0.83 TRPV1 (0.46) EPHX2GRM4TRPV1
SCHEMBL25339100 0.81 LMNA (0.43) EPHX2TRPV1
SCHEMBL30482552 0.78 EGFR (0.47) EPHX2TRPV1
SCHEMBL26202876 0.78 EGFR (0.47) EPHX2TRPV1
SCHEMBL25376256 0.78 KCNQ3 (0.48) EPHX2GRM4TRPV1
SCHEMBL21497150 0.78 EPHX2 (0.56) EPHX2TRPV1BRD4TUBB4ATUBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023146513-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
Send feedback